Fusen Pharmaceutical Co., Ltd. (HK:1652) has released an update.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Fusen Pharmaceutical Co., Ltd. has announced the passing of its Chairman, Mr. Cao Changcheng, and the appointment of his son, Mr. Cao Zhiming, as the new Chairman. The company has assured investors that this transition will not affect its business operations. Mr. Zhiming, with over 12 years of experience in securities and corporate finance, holds a significant stake in the company and is set to continue the strategic direction established by the Board.
For further insights into HK:1652 stock, check out TipRanks’ Stock Analysis page.